For a diagnosis of separation anxiety, a person must exhibit three or more symptoms that significantly impair day-to-day life for at least 4 weeks. CBT is often the first line of treatment for ...
The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.
Mania should be included in the differential diagnosis of elderly patients ... Once the patient is stable and medical causes of an acute delirium have been eliminated, treatment of the psychiatric ...
Significant variation exists in supportive care strategies for older adults with MDS and AML ... from 105 hematologists who actively treat patients with MDS/AML. The respondents practiced ...